The useflulness of 99mTC-tetrofosmin breast scintigraphy with breast specific gamma-camera (BSGC) in the detection of residual disease following neoadiuvant therapy / Spanu, Angela; Sanna, D; Chessa, F; Piras, B; Nuvoli, Susanna Maria Francesca; Madeddu, G.. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 38 (Suppl. 2):(2011), pp. PW001-PW001.

The useflulness of 99mTC-tetrofosmin breast scintigraphy with breast specific gamma-camera (BSGC) in the detection of residual disease following neoadiuvant therapy

SPANU, Angela;NUVOLI, Susanna Maria Francesca;
2011

The useflulness of 99mTC-tetrofosmin breast scintigraphy with breast specific gamma-camera (BSGC) in the detection of residual disease following neoadiuvant therapy / Spanu, Angela; Sanna, D; Chessa, F; Piras, B; Nuvoli, Susanna Maria Francesca; Madeddu, G.. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 38 (Suppl. 2):(2011), pp. PW001-PW001.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/156981
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact